Viral connection between drug rashes and autoimmune diseases: How autoimmune responses are generated after resolution of drug rashes

Autoimmunity Reviews

Volumn 8, Issue 6, 2009, Pages 488-494

  Aota, Noriko ^a   Shiohara, Tetsuo ^a  

^a KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Drug induced hypersensitivity syndrome (DIHS); Epstein Barr virus (EBV); Regulatory T (Treg) cells; Viral reactivations

Indexed keywords

ALLOPURINOL; CARBAMAZEPINE; DAPSONE; MEXILETINE; MINOCYCLINE; PHENOBARBITAL; PHENYTOIN; SALAZOSULFAPYRIDINE; ZONISAMIDE;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DRESS SYNDROME; DRUG ERUPTION; FEVER; HERPES VIRUS; HUMAN; KIDNEY DISEASE; REGULATORY T LYMPHOCYTE; REVIEW; SKIN DEFECT; VIRUS INFECTION; VIRUS REACTIVATION;

AUTOIMMUNE DISEASES; AUTOIMMUNITY; DRUG HYPERSENSITIVITY; EXANTHEMA; FORKHEAD TRANSCRIPTION FACTORS; HERPESVIRIDAE; HERPESVIRIDAE INFECTIONS; HUMANS; IMMUNE TOLERANCE; T-LYMPHOCYTES, REGULATORY; TIME FACTORS; VIRUS ACTIVATION;

EID: 65549099910     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2009.02.029     Document Type: Review

References (39)

1. James J.A., Kaufman K.M., Farris A.D., Taylor-Albert E., Lehman T.J., and Harley J.B. An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic erythematosus. J Clin Invest 100 (1997) 3019-3026
2. Gross A.J., Hochberg D., Rand W.M., and Thorley-Lawson D.A. EBV and systemic lupus erythematosus: a new perspective. J Immunol 174 (2005) 6599-6607
3. Wang H., Nicholas M.W., Conway K.L., Sen P., Tisch R.M., and Clarke S.H. EBV latent membrane protein 2A induces autoreactive B cell activation and TLR hypersensitivity. J Immunol 177 (2006) 2793-2802
4. Whittingham S., McNeilage J., and Mackay I.R. Primary Sjogren syndrome after infections mononucleosis. Ann Intern Med 102 (1985) 490-493
5. Tosato G., Steinberg A.D., Yarchoan R., Heilman C.A., Pike S.E., De Seau V., et al. Abnormality elevated frequency of Epstein-Barr virus-infected B cells in the blood of patients with rheumatoid arthritis. J Clin Invest 73 (1984) 1789-1795
6. Horwitz M.S., Ilic A., Fine C., Rodriquez E., and Sarvatnik N. Presented antigen from damaged pancreatic beta cells activates autoreactive T cells in virus-mediated autoimmune diabetes. J Clin Invest 109 (2002) 79-87
7. Vrbikova J., Janatkova I., Zamrazil V., Tomiska F., and Fucikova T. Epstein-Barr virus serology in patients with autoimmune thyroiditis. Exp Clin Endocrinol Diabetes 104 (1996) 89-92
8. Shiohara T., Inaoka M., and Kano Y. Drug-induced hypersensitivity syndrome (DIHS): a reactivation induced by a complex interplay among herpesviruses and antiviral and antidrug immune responses. Allergol Intern 55 (2006) 1-8
9. Kano Y., Hirahara K., Sakuma K., and Shiohara T. Several herpesviruses can reactivate in a severe drug-induced multiorgan reaction in the same sequential order as in graft-versus-host disease. Br J Dermatol 155 (2006) 301-306
10. Chiou C.-C., Chung W.H., Hung S.I., Yang L.C., and Hong H.S. Fulminant type 1 diabetes mellitus caused by drug hypersensitivity syndrome with human herpesvirus6 infection. J Am Acad Dermatol 54 (2006) s14-s17
11. Sekine N., Motokura T., Oki T., Umeda Y., Sasaki N., Hayashi M., et al. Rapid loss of insulin secretion in a patient with fulminant type 1 diabetes mellitus and carbamazepine hypersensitivity syndrome. JAMA 285 (2001) 1153-1154
12. Kano Y., Sakuma K., and Shiohara T. Sclerodermoid graft-versus-host disease-like lesions occurring after drug-induced hypersensitivity syndrome. Br J Dermatol 156 (2007) 1061-1063
13. Aota N, Hirahara K, Kano Y, Fukuoka T, Yamada A, Shiohara T. Systemic lupus erythematosus presenting with Kikuchi-Fujimoto disease as a long-term sequela of drug-induced hypersensitivity syndrome: a possible role of Epstein-Barr virus reactivation. Dermatology 2008 [Dec 16, Electronic publication ahead of print].
14. Verdolini R., Bugatti L., Giangiacomi M., Nicolini M., Filosa G., and Cerio R. Systemic lupus erythematosus induced by Epstein-Barr virus infection. Br J Dermatol 146 (2002) 877-881
15. Babcock G.J., Decker L.L., Freeman R.B., and Thorley-Lawson D.A. Epstein-Barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients. J Exp Med 190 (1999) 567-576
16. Kang I., Quan T., Nolasco H., Park S.H., and Hong M.S. Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus. J Immunol 172 (2004) 1287-1294
17. Vaughan J.H., Valbracht J.R., Nguyen M.D., Handley H.H., Smith R.S., Patrick K., et al. Epstein-Barr virus-induced autoimmune responses. 1. Immunoglobulin M autoantibodies to proteins mimicking and not mimicking Epstein-Barr virus nuclear antigen-1. J Clin Invest 95 (1995) 1306-1315
18. Vaughan J.H., Nguyen M.D., Valbracht J.R., Patrick K., and Rhodes G.H. Epstein-Barr virus-induced autoimmune responses. 2. Immunoglobulin G autoantibodies to mimicking and nonmimicking epitopes. Presence in autoimmune disease. J Clin Invest 95 (1995) 1316-1327
19. Sabbatini A., Bombardueri S., and Miqliorini P. Autoantibodies from patients with systemic lupus erythematous bind a shared sequence of SmD and Epstein-Barr virus-encoded nuclear antigen EBNA 1. Eur J Immunol 23 (1993) 1146-1152
20. Sundar K., Jacques S., Gottlieb P., Villars R., Benito M.E., Taylor D.K., et al. Expression of the Epstein-Barr virus nuclear antigen-a (EBNA-1) in the mouse can elicit the production of anti-dsDNA and anti-Sm antibodies. J Autoimmun 23 (2004) 127-140
21. Callan M.F., Steven N., Krausa P., Wilson J.D., Moss P.A., Gillespie G.M., et al. Large clonal expansions of CD8+ T cells in acute infections mononucleosis. Nat Med 2 (1996) 906-911
22. Callan M.F., Tan L., Annels N., Ogg G.S., Wilson J.D., O'Callaghan C.A., et al. Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus In vivo. J Exp Med 187 (1998) 1395-1402
23. Tsokos G.C., Magrath I.T., and Balow J.E. Epstein-Barr virus induces normal B cell responses but defective suppressor T cell responses in patients with systemic lupus erythematosus. J Immunol 131 (1983) 1797-1801
24. Hagiwara E., Gourley M.F., Lee S., and Klinman D.K. Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of onterleukin-10:interferon-gamma-secreting cells in the peripheral blood. Arthritis Rheum 39 (1996) 379-385
25. Hsu D.H., de Waal Malefyt R., Fiorentino D.F., Dang M.N., Vieira P., de Vries J., et al. Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1. Science 250 (1990) 830-832
26. Takayama T., Nishioka Y., Lu L., Lotze M.T., Tahara H., and Thomson A.W. Retroviral delivery of viral interleukin-10 into myeloid dendritic cells markedly inhibits their allostimulatory activity and promotes the induction of T-cell hyporesponsiveness. Transplantation 66 (1998) 1567-1574
27. Burrows S.R., Silns S.L., Khanna R., Burrows J.M., Riscmueller M., MaCluskey J., et al. Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity. Eur J Immunol 27 (1997) 1726-1736
28. Le Cleach I., Joberty C., Fillet A.M., Sutton L., Cordonnier C., Frances C., et al. Human herpesvirus 6 infection in patients with exanthema after allogeneic bone marrow transplantation. Arch Dermatol 134 (1998) 759-760
29. Kano Y., Hirahara K., Sakuma K., and Shiohara T. Several herpesviruses can reactivate in a severe drug-induced multiorgan reaction in the same sequential order as in graft-versus-host disease. Br J Dermatol 155 (2006) 301-306
30. Kano Y., Inaoka M., and Shiohara T. Association between anticonvulsant hypersensitivity syndrome and human herpesvirus 6 reactivation and hypogammaglobulinemia. Arch Dermatol 140 (2004) 183-188
31. Hashimoto K., Yasukawa M., and Tohyama M. Human herpesvirus 6 and drug allergy. Curr Opin Allergy Clin Immunol 3 (2003) 255-260
32. Shiohara T., and Kano Y. A complex interaction between drug allergy and viral infection. Clin Rev Allergy Immunol 33 (2007) 124-133
33. Shiohara T., Takahashi R., and Kano Y. Drug-induced hypersensitivity syndrome and viral reactivation. In: Pichler W.J. (Ed). Drug Hypersensitivity (2007), Karger, Basel 251-266
34. Shiohara T., Iijima M., Ikezawa Z., and Hashimoto K. The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations. Br J Dermatol 156 (2007) 1083-1084
35. Shear N.H., and Spielberg S.P. Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk. J Clin Invest 82 (1988) 1826-1832
36. Sakuma K., Kano Y., Fukuhara M., and Shiohara T. Syndrome of inappropriate secretion of antidiuretic hormone associated with limbic encephalitis in a patient with drug-induced hypersensitivity syndrome. Clin Exp Dermatol 33 (2008) 287-290
37. Zain J.A. Viral infections associated with bone marrow transplantation. Hematol/Oncol Clin North Am 4 (1990) 603-623
38. Sever J.L., South M.A., and Shaver K.A. Delayed manifestations of congenital rubella. Rev Infect Dis 1 (1985) s164-s169
39. Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 6 (2005) 345-352